Taft partner Robert A. Bilott was quoted in the Australian article "Blood Is Up Over Guidelines," published by the Newcastle Herald on May 27. The article discusses information released by Australia's federal Department of Health, which advises residents how to interpret results of blood tests for the per- and poly-fluoralkyl chemicals ("PFAS"). Bilott was quoted regarding his experience in the class action lawsuit against DuPont over the health effects of chemicals in the United States.
Bilott, who serves as co-lead counsel for the Plaintiff’s Steering Committee handling litigation against DuPont, has been in the spotlight since The New York Times Magazine dubbed him "The Lawyer Who Became DuPont's Worst Nightmare" in an article published on Jan. 6, 2016. On Feb. 13, 2017, DuPont publicly disclosed that it has reached a settlement in principle to resolve the C-8 personal injury, multi-district litigation now pending in federal court in Columbus, Ohio, for $670.7 million.
Bilott is a member of the firm's Environmental, Litigation and Product Liability and Personal Injury groups, where he represents a diverse range of clients on a wide variety of matters involving federal, state and local environmental laws and related litigation.